Law360, New York (January 17, 2018, 2:24 PM EST) — A drugmaker challenging the U.S. Patent and Trademark Office’s controversial new policy on … to an abrupt policy switch at the USPTO that demands that patent and trademark applicants who appeal to a district court pay the agency’s legal bills, …
